Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Open Access Articles

Anticancer Drugs Aimed at E6 and E7 Activity in HPV-Positive Cervical Cancer open Access plus

Volume: 12   Issue: 2
Pp: 170-184
S. Tan, E. G.E. de Vries, A. G.J. van der Zee and S. de Jong

Adding to the Mix: Fibroblast Growth Factor and Platelet-Derived Growth Factor Receptor Pathways as Targets in Non – small Cell Lung Cancer open Access plus

Volume: 12   Issue: 2
Pp: 107-123
S. A. Kono, L. E. Heasley, R. C. Doebele and D. R. Camidge

Targeting ATP7A to Increase the Sensitivity of Neuroblastoma Cells to Retinoid Therapy open Access plus

Volume: 11   Issue: 7
Pp: 826-836
B. B. Cheung and G. M. Marshall

Strategies for Overcoming Inherent and Acquired Resistance to EGFR Inhibitors by Targeting Downstream Effectors in the RAS/PI3K Pathway open Access plus

Volume: 10   Issue: 8
Pp: 824-833
A. J. Weickhardt, N. C. Tebbutt and J. M. Mariadason

Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function open Access plus

Volume: 10   Issue: 2
Pp: 155-167
A. K. Gandhi, J. Kang, L. Capone, A. Parton, L. Wu, L. H. Zhang, D. Mendy, A. Lopez-Girona, T. Tran, L. Sapinoso, W. Fang, S. Xu, G. Hampton, J. B. Bartlett and P. Schafer

Potential Uses of MicroRNA in Lung Cancer Diagnosis, Prognosis, and Therapy open Access plus

Volume: 9   Issue: 4
Pp: 572-594
Qi Zhao Wang, William Xu, Nagy Habib and Ruian Xu

S100A8 and S100A9 Overexpression Is Associated with Poor Pathological Parameters in Invasive Ductal Carcinoma of the Breast open Access plus

Volume: 8   Issue: 4
Pp: 243-252
Kazumori Arai, Sachiko Takano, Takumi Teratani, Yasuhiro Ito, Toshihiro Yamada and Ryushi Nozawa

Nutritional Modulation of Terminal End Buds: Its Relevance to Breast Cancer Prevention open Access plus

Volume: 7   Issue: 5
Pp: 465-474
Leena Hilakivi-Clarke

Ribonucleotide Reductase Inhibitors and Future Drug Design open Access plus

Volume: 6   Issue: 5
Pp: 409-431
J. Shao, B. Zhou, Bernard Chu and Y. Yen

Liposomal Muramyl Tripeptide Phosphatidylethanolamine: Targeting and Activating Macrophages for Adjuvant Treatment of Osteosarcoma open Access plus

Volume: 6   Issue: 2
Pp: 123-133
A. Nardin, M. L. Lefebvre, K. Labroquere, O. Faure and J. P. Abastado